2024
Wadenpohl T, Shein M, Steinberg J, Lehmann J B, Schütz AK, Jung S: ”Economical large-scale purification of extracellular vesicles from urine”, Separation and Purification Technology 335:126155
2023
Welsh J A, Goberdhan D C I, O’Driscoll L [and 1043 others, including S Jung]: „Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches“, Journal of Extracellular vesicles
2022
Walter AJ, van de Klundert M*, Jung S*: „Many ways to communicate – crosstalk between the HBV infected cell and its environment“, Pathogens 12(1):29
Nicolai M, Steinberg J, Obermann H-L, Venegas Solis F, Bartok E, Bauer S, Jung S: „Identification of an optimal TLR8 ligand by alternating the position of 2′-O-ribose methylation“, IJMS 23(19):11139
2021
Altstetter SM, Quitt O, Pinci F, Hornung V, Lucko AM, Wisskirchen K, Jung S*, Protzer U*: „Hepatitis-D Virus infection is resistent to innate immune response but increases cytotoxic T-cell activity“, Cells 10(11):3253
Steinberg J, Wadenpohl T, Jung S: „The Endogenous RIG-I Ligand Is Generated in Influenza A-Virus Infected Cells“, Viruses 13(8):1564
2020
Jung S, Jacobs KFK, Shein M, Schütz AK, Mohr F, Stadler H, Lucko AM, Altstetter SM, Wilsch F, Protzer U:“ Efficient and reproducible depletion of Hepatitis B virus from plasma derived extracellular vesicles“, Journal of extracellular vesicles (2):e12040
Jung S, von Thülen T, Yang I, Laukemper V, Rupf B, Janga H, Panagiotidis G, Schön A, Nicolai M, Schulte L, Obermann H-L, Weber F, Kaufmann A, Bauer S: „A Ribosmal RNA fragment with 2’,3’-cyclic phosphate and GTP- binding activity acts as RIG-I“ ligand, Nucleic Acid Research, Vol. 48, No. 18 10397–10412
Jung S, Altstetter SM, Protzer U: „Innate Immune Recognition and Modulation in Hepatitis Delta Virus Infection“, World Journal of Gastroenterology, 26(21): 2781-2791
Jung S, Altstetter SM, Wilsch F, Shein M, Schütz AK, Protzer U: „Extracellular vesicles derived from Hepatitis-D Virus infected cells induce a proinflammatory cytokine response in human peripheral blood mononuclear cells and macrophages“, Matters, https://doi.org/10.48565/rh7j-hr59
2019
Théry C, Witwer KW [and 379 others, including Jung S]: „Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines“, Journal of extracellular vesicles, 7(1):1535750
Roggendorf M, Karimzadeh H, Jung S, Neumann-Haefelin C: „New developments for prophylactic and therapeutic vaccines against HDV“, Hepatitis D. Virology, management and methodology 16: 279-294
2015
Jung S, von Thülen T, Laukemper V, Pigisch S, Hangel D, Hamm S, Wagner H, Kaufmann A, Bauer S: „A single naturally occurring 2’-O-methylation converts a TLR7 and TLR8 activating RNA into a TLR8 specific ligand“, PLoS One 10(3): e0120498.
2010
Hoenen T, Biedenkopf N, Zielecki F, Jung S, Groseth A, Feldmann H, Becker S: „Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription“, Journal of Virology 84:7053-63
Hoenen T, Jung S, Herwig A, Groseth A, Becker S: „Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription“, Virology 403:56-66
2009
Winter J*, Jung S*, Keller S, Gregory RI, Diederichs S: „Many roads to maturity: microRNA biogenesis pathways and their regulation“, Nature Cell Biology 11: 228-234
2008
Diederichs S, Jung S, Rothenberg SM, Smolen GA, Mlody BG, Haber DA: „Co-expression of Argonaute-2 enhances RNA Interference towards perfect match binding sites“, PNAS, 105: 9284-9289
Asterisks (*) indicate equal contributoin